Session

IBD: Cross-sectional

CROHN'S DISEASE REAL WORLD THERAPY IN PREVALENT CD-PATIENTS IN GERMANY - THERE IS STILL A GREAT BURDEN OF DISEASE
CROHN'S DISEASE REAL WORLD THERAPY IN PREVALENT CD-PATIENTS IN GERMANY - THERE IS STILL A GREAT BURDEN OF DISEASE

OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY
OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY
HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY

DIMINISHED SOMATIC PAIN IN ADULT PATIENTS WITH MILD-MODERATE CROHN'S DISEASE AFTER COGNITIVE BEHAVIORAL AND MINDFULNESS-BASED STRESS REDUCTION
DIMINISHED SOMATIC PAIN IN ADULT PATIENTS WITH MILD-MODERATE CROHN'S DISEASE AFTER COGNITIVE BEHAVIORAL AND MINDFULNESS-BASED STRESS REDUCTION

BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN'S PATIENTS ON BIOLOGICS: A PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES
BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN'S PATIENTS ON BIOLOGICS: A PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES

SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?
SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY
HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY

IBD: Cross-sectional

DIMINISHED SOMATIC PAIN IN ADULT PATIENTS WITH MILD-MODERATE CROHN'S DISEASE AFTER COGNITIVE BEHAVIORAL AND MINDFULNESS-BASED STRESS REDUCTION
DIMINISHED SOMATIC PAIN IN ADULT PATIENTS WITH MILD-MODERATE CROHN'S DISEASE AFTER COGNITIVE BEHAVIORAL AND MINDFULNESS-BASED STRESS REDUCTION

IBD: Cross-sectional

CROHN’S DISEASE REAL WORLD THERAPY IN PREVALENT CD-PATIENTS IN GERMANY - THERE IS STILL A GREAT BURDEN OF DISEASE
CROHN’S DISEASE REAL WORLD THERAPY IN PREVALENT CD-PATIENTS IN GERMANY - THERE IS STILL A GREAT BURDEN OF DISEASE

IBD: Cross-sectional

BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS ON BIOLOGICS: A PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES
BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS ON BIOLOGICS: A PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES

IBD: Cross-sectional

SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?
SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?

IBD: Cross-sectional

SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?
SHOULD WE EXPECT AN INCREMENTAL CLINICAL BENEFIT FROM ACHIEVING HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION?

IBD: Cross-sectional  et al.

BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS ON BIOLOGICS: A PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES
BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS ON BIOLOGICS: A PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES

IBD: Cross-sectional  et al.

DIMINISHED SOMATIC PAIN IN ADULT PATIENTS WITH MILD-MODERATE CROHN'S DISEASE AFTER COGNITIVE BEHAVIORAL AND MINDFULNESS-BASED STRESS REDUCTION
DIMINISHED SOMATIC PAIN IN ADULT PATIENTS WITH MILD-MODERATE CROHN'S DISEASE AFTER COGNITIVE BEHAVIORAL AND MINDFULNESS-BASED STRESS REDUCTION

IBD: Cross-sectional  et al.

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY
HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY

IBD: Cross-sectional  et al.

OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY
OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY

IBD: Cross-sectional  et al.

CROHN’S DISEASE REAL WORLD THERAPY IN PREVALENT CD-PATIENTS IN GERMANY - THERE IS STILL A GREAT BURDEN OF DISEASE
CROHN’S DISEASE REAL WORLD THERAPY IN PREVALENT CD-PATIENTS IN GERMANY - THERE IS STILL A GREAT BURDEN OF DISEASE

IBD: Cross-sectional  et al.

Item 1 - 17 / 17
1